Citadel Advisors’s Imunon IMNN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-52
Closed -$9K 14247
2021
Q3
$9K Sell
52
-41
-44% -$8.51K ﹤0.01% 13688
2021
Q2
$23K Sell
93
-92
-50% -$21.7K ﹤0.01% 13522
2021
Q1
$50K Buy
185
+39
+27% +$13.1K ﹤0.01% 12902
2020
Q4
$20K Buy
146
+26
+22% +$3.12K ﹤0.01% 10780
2020
Q3
$17K Sell
120
-31
-21% -$7.83K ﹤0.01% 9884
2020
Q2
$110K Buy
+151
New +$65.5K ﹤0.01% 8939
2019
Q4
Sell
-86
Closed -$26K 9401
2019
Q3
$26K Buy
86
+12
+16% +$4.11K ﹤0.01% 8876
2019
Q2
$26K Sell
74
-135
-65% -$55K ﹤0.01% 8900
2019
Q1
$80K Sell
209
-3
-1% -$1.24K ﹤0.01% 8634
2018
Q4
$59K Buy
+212
New +$88K ﹤0.01% 8446
2018
Q3
Sell
-51
Closed -$30K 9453
2018
Q2
$30K Buy
+51
New +$25.3K ﹤0.01% 8561
2016
Q1
Sell
-2
Closed -$9K 7317
2015
Q4
$9K Hold
2
﹤0.01% 8305
2015
Q3
$11K Buy
2
+1
+100% +$5.97K ﹤0.01% 8432
2015
Q2
$6K Hold
1
﹤0.01% 8512
2015
Q1
$4K Sell
1
-1
-50% -$6.96K ﹤0.01% 8350
2014
Q4
$11K Hold
2
﹤0.01% 8100
2014
Q3
$17K Sell
2
-2
-50% -$17.4K ﹤0.01% 7553
2014
Q2
$35K Sell
4
-6
-60% -$53.6K ﹤0.01% 6983
2014
Q1
$96K Buy
10
+6
+150% +$62.5K ﹤0.01% 6238
2013
Q4
$42K Hold
4
﹤0.01% 6139
2013
Q3
$55K Sell
4
-3
-43% -$44.3K ﹤0.01% 5736
2013
Q2
$93K Buy
+7
New +$97.4K ﹤0.01% 5278

Other funds holding IMNN

Citadel Advisors's IMNN Position: Q1 2025 in Review

Citadel Advisors sold out of Imunon (IMNN) in Q1 2025, closing a stake of 983 shares — an estimated $12.2K sold.

Citadel Advisors first reported a position in IMNN in Q2 2013 and held it in 32 quarters. The position peaked at $166K in Q1 2022. 16 funds tracked by Wall St. Rank hold IMNN as of Q1 2025.

  • Citadel Advisors reported no remaining Imunon position as of Q1 2025 after selling out during the quarter.
  • Citadel Advisors sold 983 Imunon shares in Q1 2025, an estimated $12.2K.
  • Citadel Advisors first reported a position in Imunon in Q2 2013 and held it in 32 quarters.
  • Citadel Advisors's Imunon position peaked at $166K in Q1 2022.
  • 16 funds tracked by Wall St. Rank held Imunon as of Q1 2025.

Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.